Meg Krench

Meg Krench is an Investor at Sanofi Ventures, the corporate venture capital arm of the multinational pharmaceutical corporation Sanofi, based in Cambridge, Massachusetts. She officially joined the life sciences-focused investment team in 2021, bringing a specialized background in biotechnology investing, corporate strategy, and business development to the fund. In her current capacity, Krench evaluates early-stage therapeutics and digital health startups, managing capital deployment for a portfolio that aligns with the broader strategic therapeutic interests of the parent organization. She leverages her advanced scientific training from the Massachusetts Institute of Technology to analyze complex life sciences transactions, assess novel clinical assets, and structure syndicated financing rounds alongside prominent industry co-investors like Atlas Venture. Ultimately, Krench focuses on identifying transformative biotechnology platforms and guiding these emerging healthcare companies through the highly regulated stages of clinical development.